Skip to main content
. Author manuscript; available in PMC: 2024 Apr 15.
Published in final edited form as: Psychopharmacology (Berl). 2020 May 22;237(8):2367–2380. doi: 10.1007/s00213-020-05540-w

Table 1.

Subject characteristics. Variables are means (SD), or n (percentage) as appropriate

Pioglitazone (n = 6) Placebo (n = 8) Total (n = 14a) p valueb
Demographics
 Age 49.7 (6.6) 43.3 (6.0) 46.0 (6.8) 0.08
 Male 6 (100%) 7 (87.5%) 13 (92.9%) 0.37
 Black/African Americanc 5 (83.3%) 4 (50.0%) 9 (64.3%) 0.40
 Education (years) 13.3 (2.4) 12.5 (4.0) 12.9 (3.3) 0.66
 Smoker 5 (83.3%) 5 (62.5%) 10 (71.4%) 0.39
 Fagerstrom Score 3.2 (3.1) 3.0 (1.7) 3.1 (2.4) 0.90
 Family history densityd 0.2 (0.1) 0.1 (0.1) 0.1 (0.1) 0.27
Alcohol-related measures
 Avg. drinks/drinking day 10.4 (4.3) 14.3 (4.0) 12.6 (4.4) 0.11
 Heavy drinking days 67.5 (27.3) 76.4 (15.0) 72.6 (20.7) 0.45
 ADSe score 19.2 (9.0) 12.9 (6.4) 15.6 (8.0) 0.15
 PACSf craving 16.3 (8.6) 7.3 (3.5) 11.1 (7.5) 0.05
Psychological characteristics
 Current anxiety disorder 1 (16.7%) 2 (25.0%) 3 (21.4%) 0.71
 Current mood disorder 0 (0.0%) 1 (12.5%) 1 (7.1%) 0.37
 Current substance use disorderg 1 (16.7%) 0 (0.0%) 1 (7.1%) 0.23
 CTQh total score 41.5 (20.4) 41.6 (9.2) 41.6 (14.3) 0.98
 Neuroticism score 53.3 (7.2) 54 (6.8) 53.7 (6.7) 0.86
 CPRSi anxiety 12.5 (7.9) 9.9 (6.6) 11 (7.0) 0.51
 CPRS depression 13.7 (8.3) 13.1 (7.2) 13.4 (7.4) 0.90
a

Of the 14 subjects, 13 completed the entire protocol while 1 subject completed the scripts challenge but not the LPS challenge

b

Based on a chi-square test for categorical measures, and a t test for continuous measures

c

The remaining subjects were White/Caucasian (4) and Asian (1)

d

Calculated as the proportion of first- and second-degree relatives known to have been treated for alcohol abuse or have alcohol use–related problems, as measured by the Family Tree Questionnaire (FTQ)

e

Alcohol Dependence Scale

f

Penn Alcohol Craving Scale

g

Substances other than alcohol

h

Childhood Trauma Questionnaire

i

Comprehensive Psychopathological Rating Scale